Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.46 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.43 |
| ▸ | GABRP | O00591 | 1/20 | 0.43 |
| ▸ | GABRD | O14764 | 1/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.43 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.43 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.43 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28492068 | 0.97 | LMNA (0.50) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL866445 | 0.92 | LMNA (0.58) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL8759579 | 0.90 | TSHR (0.60) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL10442027 | 0.90 | TSHR (0.60) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL5247469 | 0.90 | TSHR (0.60) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL19706336 | 0.90 | TSHR (0.60) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL7813622 | 0.90 | TSHR (0.60) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL5249605 | 0.90 | TSHR (0.60) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL21850118 | 0.90 | TSHR (0.60) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL10442148 | 0.90 | TSHR (0.60) | LMNASLC22A6TSHRNFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 503 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025025370-A1 | COATING COMPOSITION HAVING MOLD-PROOF AND ANTIBACTERIAL PROPERTIES AND PREPARATION METHOD THEREFOR | 江西永通科技股份有限公司 | 2025-02-06 | — | — | WO | claimed |
| CN-108538572-B | Capacitor packaging structure | 钰邦电子（无锡）有限公司 | 2020-09-04 | — | — | CN | claimed |
| CN-107502412-B | High-temperature-resistant magnesium salt lubricating oil detergent and preparation method thereof | 黄山学院 | 2020-02-14 | — | — | CN | claimed |
| US-10361036-B2 | Capacitor package structure | APAQ TECHNOLOGY CO., LTD. (TW) | 2019-07-23 | — | — | US | claimed |
| CN-108538572-A | Capacitor packaging structure | 钰邦电子（无锡）有限公司 | 2018-09-14 | — | — | CN | claimed |
| US-20180254148-A1 | CAPACITOR PACKAGE STRUCTURE | APAQ TECHNOLOGY CO., LTD. (TW) | 2018-09-06 | — | — | US | claimed |
| CN-107502412-A | A kind of high temperature resistant type magnesium salts detergent for lubricating oil and preparation method thereof | 黄山学院 | 2017-12-22 | — | — | CN | claimed |
| US-7772221-B2 | Diaminopropane derived macrocycles as inhibitors of β amyloid production | BRISTOL-MEYERS SQUIBB COMPANY (US) | 2010-08-10 | — | — | US | claimed |
| US-20080194535-A1 | DIAMINOPROPANE DERIVED MACROCYCLES AS INHIBITORS OF BETA AMYLOID PRODUCTION | BRISTOL-MYERS SQUIBB COMPANY | 2008-08-14 | — | — | US | claimed |
| EP-4029868-B1 | MCL-1 INHIBITORS | GILEAD SCIENCES INC (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-4737477-A2 | HEPCIDIN MIMETICS FOR TREATMENT OF HEREDITARY HEMOCHROMATOSIS | Protagonist Therapeutics, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-4706671-A2 | CONJUGATED HEPCIDIN MIMETICS | Protagonist Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4700017-A2 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | Acuitas Therapeutics Inc. (CA) | 2026-02-25 | — | — | EP | disclosed |
| US-20260035359-A1 | HERBICIDAL IMIDAZOLE COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2026-02-05 | — | — | US | disclosed |
| US-4895587-A | Haloacetamide compounds, process for production thereof, and use thereof as herbicide | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1990-01-23 | — | — | US | disclosed |
| EP-0206251-B1 | HALOACETAMIDE COMPOUNDS, PROCESS FOR PRODUCTION THEREOF, AND USE THEREOF AS HERBICIDE | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1988-09-07 | — | — | EP | disclosed |
| CN-87102455-A | Diphenyl ether derivatives pesticide compound | — | 1988-01-27 | — | — | CN | disclosed |
| US-4552883-A | CNS DEPRESSANTS, ANXIOLYTICS | ICI AMERICAS INC. (US) | 1985-11-12 | — | — | US | disclosed |
| EP-0096995-A2 | Pyrazolopyridine compounds | ICI AMERICAS INC. (US) | 1983-12-28 | — | — | EP | disclosed |
| US-3957672-A | FLUORINATED POLYETHERS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194535-A1 | DIAMINOPROPANE DERIVED MACROCYCLES AS INHIBITORS OF BETA AMYLOID PRODUCTION | APP, BACE1, BACE2 | LMNA 489/4885SLC22A6 3048/4885TSHR 3180/4885 |
| US-20260035359-A1 | HERBICIDAL IMIDAZOLE COMPOUNDS | CBR3, CBR1, CLIC1 | LMNA 3581/4885SLC22A6 2493/4885TSHR 864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.